Home › Companies › Ligand Pharmaceuticals Incorporated › 2025-2026
Compiled from SEC Form N-PX filings and Ligand Pharmaceuticals Incorporated’s Form 8-K, filed 2026-06-09 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Ligand Pharmaceuticals Incorporated in the interactive database Compare manager voting policies
These tallies are Ligand Pharmaceuticals Incorporated’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-09 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Jason M. Aryeh | 14,373,659 | -- | -- | 3,160,100 | 1,257,231 | Majority: yes |
| Elect Director: Todd C. Davis | 17,224,372 | -- | -- | 309,387 | 1,257,231 | Majority: yes |
| Elect Director: Nancy R. Gray, Ph.D. | 16,915,084 | -- | -- | 618,675 | 1,257,231 | Majority: yes |
| Elect Director: Jason Haas | 17,204,420 | -- | -- | 329,339 | 1,257,231 | Majority: yes |
| Elect Director: John W. Kozarich, Ph.D. | 16,260,105 | -- | -- | 1,273,654 | 1,257,231 | Majority: yes |
| Elect Director: John L. LaMattina, Ph.D. | 16,714,494 | -- | -- | 819,265 | 1,257,231 | Majority: yes |
| Elect Director: Stephen L. Sabba, M.D. | 16,552,676 | -- | -- | 981,083 | 1,257,231 | Majority: yes |
| Elect Director: Martine Zimmermann, Pharm.D. | 17,319,859 | -- | -- | 213,900 | 1,257,231 | Majority: yes |
| Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved. | 16,497,712 | 1,021,948 | 14,099 | -- | 1,257,231 | Majority: yes |
| Proposal 4. The approval of an amendment and restatement of the Company's 2002 Stock Incentive Plan. In accordance with the results below, the proposal was approved. | 16,643,281 | 870,556 | 19,922 | -- | 1,257,231 | Majority: yes |
Source: Ligand Pharmaceuticals Incorporated, Form 8-K, filed with the SEC on 2026-06-09 — read the filing on EDGAR.
Each item below shows how the 398 asset managers that disclosed a Ligand Pharmaceuticals Incorporated vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Ligand Pharmaceuticals Incorporated’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 16,497,712 for, 1,021,948 against, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 82% for, 5% against (87% of the company cast a for/against vote).
The 392 asset managers below cast 94% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the company's reported shares outstanding.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,438,531 | 2 | 0 | 0 | For |
| BlackRock | 2,310,502 | 276 | 0 | 0 | For |
| Janus Henderson | 1,848,508 | 0 | 0 | 0 | For |
| Fidelity | 1,650,574 | 0 | 0 | 0 | For |
| Invesco | 434,962 | 1,000,603 | 0 | 0 | Against |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| State Street | 596,705 | 691 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 596,452 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 559,785 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Loomis Sayles | 533,687 | 0 | 0 | 0 | For |
| Victory Capital | 533,188 | 0 | 0 | 0 | For |
| NOMURA INVESTMENT MANAGEMENT BUSINESS TRUST | 517,057 | 0 | 0 | 0 | For |
| CONGRESS ASSET MANAGEMENT CO | 485,424 | 0 | 0 | 0 | For |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 409,386 | 0 | 0 | 0 | For |
| Stephens Investment Management Group LLC | 409,036 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| Chicago Capital, LLC | 353,324 | 0 | 0 | 0 | For |
| Charles Schwab | 346,850 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,216 | 0 | 0 | 0 | For |
| Northern Trust | 241,457 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 230,797 | 0 | 0 | 0 | For |
| Ranger Investment Management, L.P. | 230,027 | 0 | 0 | 0 | For |
Showing the 25 largest of 392 asset managers. See all 392 in the interactive database.
Combines 5 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Proposal 4. The approval of an amendment and restatement of the Company's 2002 Stock Incentive Plan. In accordance with the results below, the proposal was approved.”): 16,643,281 for, 870,556 against, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 83% for, 4% against (87% of the company cast a for/against vote).
The 114 asset managers below cast 99.5% of the shares they voted on this item FOR (11,286,259 for, 54,921 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,273,208 | 5,617 | 0 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 208,976 | 293 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Private Capital Management, LLC | 143,791 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
Showing the 25 largest of 114 asset managers. See all 114 in the interactive database.
Combines 7 wordings of this item as funds reported it.
82% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jason M. Aryeh”): 14,373,659 for, 3,160,100 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 72% for, 16% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (10,004,866 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,275,739 | 0 | 3,086 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 0 | 391,300 | 0 | Abstain |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 2,618 | 0 | 206,651 | 0 | Abstain |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 68,995 | 0 | Abstain |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 12,482 | 0 | 51,975 | 0 | Abstain |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 23,654 | 0 | 30,383 | 0 | Abstain |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 2 wordings of this item as funds reported it.
99.9% fund support · no official result
The 109 asset managers below cast 99.9% of the shares they voted on this item FOR (11,160,541 for, 8,432 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,824 | 1 | 0 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 15 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Jason Haas”): 17,204,420 for, 329,339 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 86% for, 2% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (11,196,362 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,824 | 0 | 1 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 8 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: John L. LaMattina, Ph.D.”): 16,714,494 for, 819,265 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 83% for, 4% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (11,196,237 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,820 | 0 | 5 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 15 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 7 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: John W. Kozarich, Ph.D.”): 16,260,105 for, 1,273,654 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 81% for, 6% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (10,861,686 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,817 | 0 | 8 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 15 | 0 | For |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 68,995 | 0 | Abstain |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 7 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Nancy R. Gray, Ph.D.”): 16,915,084 for, 618,675 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 84% for, 3% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (10,962,025 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,821 | 0 | 4 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Loomis Sayles | 0 | 0 | 192,458 | 0 | Abstain |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 7 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Stephen L. Sabba, M.D.”): 16,552,676 for, 981,083 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 83% for, 5% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (11,096,021 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,818 | 0 | 7 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 15 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 68,995 | 0 | Abstain |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Todd C. Davis”): 17,224,372 for, 309,387 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 86% for, 2% withheld (87% of the company cast a for/withheld vote).
The 109 asset managers below cast 100% of the shares they voted on this item FOR (11,189,583 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,275,762 | 0 | 3,063 | 0 | For |
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,254 | 0 | 15 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 64,457 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
Showing the 25 largest of 109 asset managers. See all 109 in the interactive database.
Combines 4 wordings of this item as funds reported it.
99% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Elect Director: Martine Zimmermann, Pharm.D.”): 17,319,859 for, 213,900 withheld, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 86% for, 1% withheld (87% of the company cast a for/withheld vote).
The 82 asset managers below cast 100% of the shares they voted on this item FOR (8,366,215 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,278,707 | 0 | 0 | 0 | For |
| Fidelity | 1,073,532 | 0 | 0 | 0 | For |
| JANUS INVESTMENT FUND | 773,070 | 0 | 0 | 0 | For |
| Invesco | 681,557 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 550,000 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 391,300 | 0 | 0 | 0 | For |
| MFS | 357,693 | 0 | 0 | 0 | For |
| DWS | 279,177 | 0 | 0 | 0 | For |
| Victory Capital | 234,777 | 0 | 0 | 0 | For |
| State Street | 209,269 | 0 | 0 | 0 | For |
| Charles Schwab | 162,350 | 0 | 0 | 0 | For |
| IMPAX FUNDS SERIES TRUST I | 152,444 | 0 | 0 | 0 | For |
| Dimensional | 98,869 | 0 | 0 | 0 | For |
| Goldman Sachs | 76,226 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 68,995 | 0 | 0 | 0 | For |
| First Trust | 68,524 | 0 | 0 | 0 | For |
| Lincoln Financial | 63,152 | 0 | 0 | 0 | For |
| OLD WESTBURY FUNDS INC | 62,425 | 0 | 0 | 0 | For |
| Russell Investments | 49,605 | 0 | 0 | 0 | For |
| Brighthouse | 46,201 | 0 | 1,900 | 0 | For |
| Allspring | 48,079 | 0 | 0 | 0 | For |
| Equitable | 42,681 | 0 | 0 | 0 | For |
| American Century | 40,485 | 0 | 0 | 0 | For |
| TIAA | 40,094 | 0 | 0 | 0 | For |
| AMERICAN BEACON FUNDS | 37,983 | 0 | 0 | 0 | For |
Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 31 asset managers below cast 100% of the shares they voted on this item FOR (2,830,147 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 1,864,732 | 0 | 0 | 0 | For |
| PROFESSIONALLY MANAGED PORTFOLIOS | 286,905 | 0 | 0 | 0 | For |
| Loomis Sayles | 192,458 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 137,169 | 0 | 0 | 0 | For |
| BUFFALO FUNDS | 60,342 | 0 | 0 | 0 | For |
| AMG FUNDS | 58,521 | 0 | 0 | 0 | For |
| Jackson National | 54,037 | 0 | 0 | 0 | For |
| Calamos | 51,250 | 0 | 0 | 0 | For |
| JPMorgan | 50,145 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 31,409 | 0 | 0 | 0 | For |
| John Hancock | 10,470 | 0 | 0 | 0 | For |
| RBB Fund Trust | 7,332 | 0 | 0 | 0 | For |
| Allianz | 6,042 | 0 | 0 | 0 | For |
| EA Series Trust | 3,649 | 0 | 0 | 0 | For |
| Brighthouse | 3,516 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 2,336 | 0 | 0 | 0 | For |
| Investment Managers Series Trust | 1,899 | 0 | 0 | 0 | For |
| Harbor Funds II | 1,727 | 0 | 0 | 0 | For |
| Pacer Funds Trust | 1,317 | 0 | 0 | 0 | For |
| Lincoln Financial | 1,305 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 978 | 0 | 0 | 0 | For |
| RIVERPARK FUNDS TRUST | 881 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 554 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 280 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 252 | 0 | 0 | 0 | For |
Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.
100% fund support · no official result
The 3 asset managers below cast 100% of the shares they voted on this item FOR (15,613 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Empower | 14,128 | 0 | 0 | 0 | For |
| FORUM FUNDS | 1,285 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 200 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 16,497,712 for, 1,021,948 against, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 82% for, 5% against (87% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (730 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Arista Wealth Management, LLC | 630 | 0 | 0 | 0 | For |
| Empower | 100 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Ligand Pharmaceuticals Incorporated’s own tally for this item (“Proposal 3. The approval of a non-binding advisory resolution regarding the compensation of the Company's named executive officers. In accordance with the results below, the proposal was approved.”): 16,497,712 for, 1,021,948 against, per its Form 8-K filed 2026-06-09 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 20,041,061 outstanding shares: 82% for, 5% against (87% of the company cast a for/against vote).
The 2 asset managers below cast 100% of the shares they voted on this item FOR (71,298 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fiera Capital Corp | 71,298 | 0 | 0 | 0 | For |
| National Philanthropic Trust | 0 | 0 | 0 | 0 | Not Voted |
Ranked by the number of Ligand Pharmaceuticals Incorporated shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 20,041,061 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 12.17% |
| 2 | BlackRock | 11.53% |
| 3 | Janus Henderson | 9.22% |
| 4 | Fidelity | 8.24% |
| 5 | Invesco | 7.16% |
| 6 | JANUS INVESTMENT FUND | 3.86% |
| 7 | State Street | 2.98% |
| 8 | FRANKLIN ADVISERS INC | 2.98% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.79% |
| 10 | Franklin Custodian Funds | 2.74% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Ligand Pharmaceuticals Incorporated | 40.23% | 13D |
| BlackRock | 14.78% | 13F |
| Vanguard Group | 10.35% | 13F |
| Vanguard Portfolio Management | 5.53% | 13G |
| Janus Henderson Group plc | 5.20% | DEF14A |
| Invesco | 4.11% | 13F |
| State Street | 3.89% | 13F |
| FMR (Fidelity) | 2.97% | 13F |
| Franklin Templeton | 2.86% | 13F |
| Dimensional Fund Advisors | 2.12% | 13F |
Percentages above are of 20,041,061 shares outstanding, as reported by Ligand Pharmaceuticals Incorporated on its Form 10-Q dated 2026-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Ligand Pharmaceuticals Incorporated’s 10-Q dated 2026-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Ligand Pharmaceuticals Incorporated's shareholder meeting held 2026-06-05, in the 2025-2026 proxy season, 398 asset managers reported how they voted in their SEC Form N-PX filings, covering 4,708 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation of the named executive officers — FOR was 94% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Ligand Pharmaceuticals Incorporated's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-09.
Ligand Pharmaceuticals Incorporated proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).